These final results, along with a past report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 aid the strategy of focusing on ACKR3 as a singular approach to modulate the opioid program, which could open new therapeutic avenues for opioid-associated Ailments. “All round, the invention https://georgea792wph7.topbloghub.com/profile